HMGN1 and hepatocellular carcinoma: TEX loaded with the N-terminus of HMGN1 (NIND) could activate DCs; these pulsed DCs significantly suppressed tumor growth through elevation of CD8+T cells and reduction of Treg cells in multiple cancer types, including hepatocellular carcinoma (HCC), pancreatic cancer and breast cancer [7].